$Summit Therapeutics (SMMT.US)$ fell nearly 20% Tuesday as the biotech firm's stock continued to give back part of a 280%+ rally that it saw last Thursday on positive study results for its candidate cancer drug ivonescimab.
SMMT sank to as low as $7.26 intraday, down 17.9% on the session and 35.5% from its $11.25 intraday peak last Thursday.
Summit had rallied 284% intraday last Thursday, rising to as high as $11.25...

a picture worth thousand words
the  CAGR for world’s  semiconductor sales from 2023 is estimated at a growth rate of  9.64%, spanning across a period of 8 years
2023 -estimated approximately  USD 525 mil
2030 -estimated to hit USD 1 trillion marks
of course there will be cyclicality in between
ETF that has it all :
$Direxion Daily Semiconductor Bull 3x Shares ETF (SOXL.US)$
$VanEck Semiconductor ETF (SMH.US)$
$iShares Semiconductor ETF (SOXX.US)$
$NVIDIA (NVDA.US)$ $Broadcom (AVGO.US)$ $ON Semiconductor (ON.US)$ $Advanced Micro Devices (AMD.US)$ $Wolfspeed (WOLF.US)$ $Tesla (TSLA.US)$ $Microsoft (MSFT.US)$ $Apple (AAPL.US)$

Bonds have had the roughest year in decades and they are primed to rebound in 2023 with a fed pause!  If you haven’t looked at $Vanguard Total Bond Market ETF (BND.US)$ , you will want to.  I have been loading up on this and will continue to.  2023 will be the year of the bond!